Search

everythinglearnresearchcommunity

for

Search:↓

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

PRP helps tissue repair but lacks standard preparation methods.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

We need better research to improve alopecia treatment and patient care.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Baricitinib is effective and safe for treating severe alopecia areata.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

New alopecia treatments aim for better results and fewer side effects.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Dupilumab for skin problems might reactivate hair loss in some patients.

Interleukin-6 may play a role in causing alopecia areata.

People with Alopecia Areata have a higher risk of heart-related health issues.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Tailored combination therapy improves non-scarring alopecia outcomes.

These gene variations are not linked to alopecia areata in Egyptians.

The MPV/PC ratio can help assess disease activity in alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

White and yellow dots indicate severe female hair loss in dark skin.